Emilie Roncali

Dr. Emilie Roncali is an Assistant Project Scientist in the Department of Biomedical Engineering at UC Davis. She received her Ph.D. in Biomedical Engineering from the Ecole Centrale de Paris, France before joining Dr. Simon Cherry’s group at UC Davis for her postdoctoral training. Dr. Roncali’s research involves molecular imaging and therapy, with an emphasis on new technology for positron emission tomography (PET) and quantitative dosimetry for radionuclide therapy. Dr. Roncali has developed optical models for Monte Carlo simulation of PET detectors and applied these models to the optimization of fast detectors using Cerenkov light. She currently focuses her simulation developments on personalized dosimetry for internal radionuclide therapy. Dr. Roncali is a member of two working groups for the National Cancer Institute (NCI) as well as an investigator of the Informatics Technology for Cancer Research (ITCR) initiative to develop new dosimetry methods for targeted radionuclide therapy (TRT) with the goal of improving treatment planning and optimizing TRT clinical trials. Specifically, she is developing image-based and simulation-based dosimetry for yttrium-90 radioembolization for advanced liver cancer treatment.